DHR Health to Provide Neuroscience Update for Clinicians, Sept. 20th

Translate to Spanish or other 102 languages!

DHR Health is hosting “Neuroscience in Clinical Practice: 2025 Update” on Saturday, September 20 at the Edinburg Conference Center at Renaissance. Image: DHRE Health Facebook
DHR Health is hosting “Neuroscience in Clinical Practice: 2025 Update” on Saturday, September 20 at the Edinburg Conference Center at Renaissance. Image: DHRE Health Facebook
- Advertisement -

EDINBURG, Texas –  According to the World Health Organization (WHO), over 1 in 3 people are affected by neurological conditions, making them the leading cause of illness and disability worldwide. With the growing prevalence of these conditions, it is essential that clinicians remain up to date on evidence-based practices for recognizing, diagnosing, treating, and managing complex neurological cases.

To meet this need, DHR Health is hosting “Neuroscience in Clinical Practice: 2025 Update” on Saturday, September 20 at the Edinburg Conference Center at Renaissance.

The daylong course is designed for clinicians who care for patients with neurological disorders and will provide a practical review with emphasis on recent advances and current guidelines. Topics will include REM sleep disorders, stroke and arrhythmia detection, epilepsy monitoring, Alzheimer’s disease and neuropsychology, neurologic emergencies, and more.

- Advertisement -
Courtesy image

The event will feature a lineup of distinguished faculty, including nationally recognized experts such as Dr. Kenneth Gaines of Vanderbilt University, Dr. William Ondo of Houston Methodist Neurological Institute, Dr. Steven Messe of the University of Pennsylvania, and Dr. Elizabeth Maher of UT Southwestern Medical Center, along with leading specialists from DHR Health.

This course is open to healthcare professionals including physicians, advanced practice providers, nurses, first responders, as well as current medical and nursing students. Pre-registration is strongly encouraged.

For more information or to register, please call the DHR Health Office of Continuing Medical Education at (956) 362-3240.  

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

The Impact of Physical Activity on Parkinson’s Decline

For 68-year-old Robert Kennedy, a retired Florida Power and Light foreman, the secret to managing his Parkinson symptoms is movement.

FDA Approves First-of-Its-Kind Chronic Hepatitis B Treatment 

The U.S. Food and Drug Administration approved Hibsago (bepirovirsen) injection, in combination with existing antiviral therapy, to treat chronic hepatitis B virus (HBV) infection in certain adults without cirrhosis.

Social Security Administration Corrects Millions of Records in Major Database Cleanup

The Social Security Administration (SSA) announced on October 20, 2026, that it has corrected millions of Social Security number records in what the agency describes as its most comprehensive record-integrity initiative in 91 years.

FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women

The U.S. Food and Drug Administration approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg per day/0.015 mg), a transdermal hormone therapy patch for women with an intact uterus applied once a week. The approval aligns with FDA’s Public Health Pillar: Increasing Access to Affordable Medicines & Medical Products.
- Advertisement -